Urothelial carcinoma, also known as transitional cell carcinoma, is a malignant tumor disease that affects the lining of the urinary tract in dogs. It is the most common form of bladder cancer in dogs and can also affect the urethra and prostate.<\/p>","ursachen":"
Basically, urothelial carcinoma develops from the transitional cells that line the mucous membrane of the urinary tract. These cells have the ability to stretch and contract, which is crucial for the function of the bladder and urinary tract. During malignant transformation, the cells undergo genetic mutations that lead to uncontrolled growth and tumor formation.<\/p> \n
The exact causes of urothelial carcinoma are not fully understood, but several factors can increase the risk. These include genetic predispositions, environmental factors, and possibly dietary influences. Certain breeds such as Scottish Terriers, West Highland White Terriers, and Beagles appear to have a higher susceptibility to this type of tumor.<\/p> \n
Environmental factors also play a role. There is evidence that exposure to certain chemicals, such as pesticides and herbicides, can increase the risk of developing urothelial carcinoma. Furthermore, tobacco smoke is a known risk factor for bladder cancer in humans and could also play a role in dogs that are exposed to passive smoke.<\/p> \n
Hormonal influences and chronic inflammatory conditions of the urinary tract are also discussed as possible risk factors. Chronic inflammatory conditions can lead to increased cell turnover, which increases the likelihood of genetic mutations that can ultimately lead to cancer.<\/p>","auswahl_symptome_rot":[33940,34291,34287,34289,33972,33620,33621,33730,34279,34286,34231,34178],"auswahl_symptome_blau":[34286,34289,34279,33730,34231,33810],"auswahl_symptome_grun":[34178,33332,34301,33621,33620],"erganzungen_zu_symptomen":"
The symptoms of urothelial carcinoma in dogs can be varied and depend on the size and location of the tumor. Common signs include bloody urine (hematuria), which can be both visible and microscopic. This is often one of the first symptoms noticed by owners.<\/p> \n
Additionally, dogs may show frequent urination (pollakiuria), Pain or difficulty urinating (dysuria). In some cases, a complete blockage of the urinary tract can occur, which is a medical emergency as the dog cannot urinate.<\/p> \n
Other symptoms may include general signs of discomfort such as loss of appetite, Weight loss, lethargy, or changes in behavior. These non-specific symptoms often indicate that the tumor is already advanced.<\/p>","zusammenfassung":"
Urothelial carcinoma in dogs develops from the cells lining the urinary tract and is caused by genetic mutations leading to uncontrolled growth. Although the exact causes are unknown, genetic predispositions, environmental factors, and possibly nutrition play a role. Certain dog breeds such as Scottish Terriers, West Highland White Terriers, and Beagles are more susceptible. Exposure to chemicals like pesticides and herbicides, as well as passive smoking, increases the risk. Symptoms include difficulty urinating, frequent urination in small amounts, blood in the urine, uncontrolled urination, Abdominal pain, and loss of appetite. Diagnosis involves a clinical examination, urine test, imaging, and a biopsy. Therapy often requires surgery, chemotherapy, and radiation therapy to control tumor growth and improve quality of life. The prognosis is cautious to poor, as the cancer is aggressive and prone to metastasis. Early diagnosis and good response to therapy can improve the prognosis. Prevention measures include avoiding carcinogens and maintaining a healthy diet. Regular veterinary examinations are important for early detection of changes, especially in at-risk breeds.<\/p>","diagnose":"
The diagnosis of urothelial carcinoma usually begins with a thorough clinical examination and medical history. The veterinarian will ask about symptoms and perform a physical examination to detect signs of urinary tract obstruction or other physical changes.<\/p> \n
A urine test is an important first step to confirm the presence of blood or abnormal cells in the urine. A cytology of the urine can help identify tumor cells, although this is not always possible.<\/p> \n
Imaging procedures such as ultrasound or X-rays of the abdomen can be used to determine the exact location and size of the tumor and to ascertain whether there are metastases. A contrast study of the urinary tract, known as urethrocystography, can also be helpful in assessing the extent of the disease.<\/p> \n
A definitive diagnosis usually requires a biopsy of the tumor tissue. This can be done through a cystoscopy, where a flexible endoscope is inserted into the bladder, or through a surgical biopsy. Histopathological examination of the tissue can confirm the presence of cancer cells and assess the degree of malignancy.<\/p>","behandlung":"
The therapy of urothelial carcinoma in dogs is often complex and requires a multimodal approach. Surgery, chemotherapy, and radiation therapy are the mainstays of therapy.<\/p> \n
Surgical interventions may be considered if the tumor is localized and complete removal seems possible. Since the bladder is a vital organ, the extent of resection may be limited, and complete removal of the tumor is often difficult.<\/p> \n
Chemotherapy is often used to slow tumor growth and control metastases. A combination of medications such as mitoxantrone and piroxicam has proven effective, although the response to therapy can vary individually.<\/p> \n
Radiation therapy may be an option for dogs where the tumor cannot be surgically removed. It can help alleviate symptoms and control tumor growth.<\/p> \n
Palliative treatments aimed at improving the dog's quality of life are also important. These include Pain management and the therapy of urinary tract infections, which frequently occur with this type of cancer.<\/p>","prognose":"
The prognosis for dogs with urothelial carcinoma is often cautious to poor, as the disease is generally aggressive and has a tendency to metastasize. Survival time can vary greatly and depends on factors such as tumor stage, therapy, and the dog's individual response.<\/p> \n
Dogs diagnosed early and responding well to therapy may have a better prognosis. However, it is important to note that a complete cure is rare, and therapy often aims to improve quality of life and control the disease.<\/p> \n
Regular follow-up examinations are crucial to monitor the progress of the disease and adjust treatment accordingly.<\/p>","ausblick_auf_aktuelle_forschung":"","zusatzlicher_inhalt_im_hauptteil":"
Since the exact causes of urothelial carcinoma are not fully known, there is no guaranteed method of prevention. Nevertheless, some measures can be taken to reduce the risk.<\/p> \n
An important step is to minimize contact with known carcinogens. This includes avoiding pesticides and herbicides in the home environment, as well as reducing exposure to tobacco smoke.<\/p> \n
A healthy diet can also play a role in prevention. Feeding a balanced, high-quality diet can help strengthen the immune system and promote overall health.<\/p> \n
Regular veterinary examinations are important to detect changes in health status early. For breeds with an increased risk of urothelial carcinoma, closer monitoring may be advisable.<\/p>","haufig_gestellte_fragen_faqs":"","literaturangaben":"","symptome_ausgeblendet":"","erganzungen":"","faq":[{"frage":"1. What is urothelial carcinoma?","antwort":"Urothelial carcinoma (also called transitional cell carcinoma or TCC) is a malignant tumor arising from the lining cells of the urinary tract. In dogs, the bladder is most often affected, followed by the urethra, ureters and renal pelvis. It is the most common tumor of the lower urinary tract in dogs."},{"frage":"2. Which dogs are at greatest risk?","antwort":"Older female dogs, neutered animals and certain breeds are predisposed: Scottish Terriers (carrying the highest known risk), West Highland White Terrier, Shetland Sheepdog, Beagle and Wire Fox Terrier. Obesity, exposure to pesticides and herbicides and a diet low in vegetables are recognized risk factors."},{"frage":"3. What symptoms do affected dogs show?","antwort":"Typical signs include hematuria (bloody urine), increased urgency, painful urination and sometimes complete urinary obstruction when the tumor blocks the urethra. The signs are often initially mistaken for a urinary tract infection but do not respond durably to antibiotics."},{"frage":"4. How is the diagnosis made?","antwort":"Bladder ultrasound usually reveals a nodular or polypoid thickening of the bladder wall, frequently at the trigone. Urine sediment cytology, the CADET BRAF test (a mutation-based urine assay) and ultimately histology from a biopsy confirm the diagnosis. CT or radiographs are used to evaluate spread."},{"frage":"5. How is urothelial carcinoma treated?","antwort":"Complete surgical removal is rarely possible because tumors are typically located at the trigone. Standard medical therapy combines non-steroidal anti-inflammatory drugs (piroxicam, meloxicam) with chemotherapy using mitoxantrone, vinblastine or toceranib. Selected cases may benefit from urethral stenting or radiation therapy."},{"frage":"6. What is the role of the CADET BRAF test?","antwort":"About 85 percent of urothelial carcinomas carry a specific BRAF mutation that can be detected in the urine. The CADET BRAF test is non-invasive, highly specific and allows early diagnosis before the tumor mass becomes visible on ultrasound. It is increasingly recommended as a screening tool in predisposed breeds."},{"frage":"7. What is the prognosis for urothelial carcinoma?","antwort":"The prognosis is guarded. With chemotherapy and non-steroidal anti-inflammatories, median survival is around 8 to 12 months. Tumors at the bladder apex have a better prognosis because they are more amenable to surgery. Without treatment, the disease usually progresses to death within a few months."},{"frage":"8. How high is the risk of metastasis?","antwort":"About 20 percent of dogs already have metastases at diagnosis, most commonly in the sublumbar lymph nodes and lungs. Roughly half of all patients eventually develop metastases. A complete staging work-up with thoracic radiographs or CT is essential before starting treatment."},{"frage":"9. When is a urethral stent needed?","antwort":"A stent is placed when the tumor obstructs the urethra so severely that urination is no longer possible. The stent is positioned minimally invasively under fluoroscopy and creates an open channel. It markedly improves quality of life but may cause incontinence by impairing sphincter function."},{"frage":"10. What can be done to reduce the risk?","antwort":"In predisposed breeds such as the Scottish Terrier, regular screening with urinalysis and the CADET BRAF test from middle age onward is sensible. Avoiding pesticide exposure (especially herbicides on lawns), weight control and a vegetable-rich diet may help reduce the risk."}],"faq_html":null},"yoast_head":"\n